A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma
Condition: Osteosarcoma Interventions: Drug: Lenvatinib; Drug: Ifosfamide; Drug: Etoposide Sponsor: Eisai Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials